PORTLAND, Maine — A groundbreaking study investigating the results of ElleVet Sciences CBD+CBDA oil and its efficacy on dogs with seizures was completed and results show a significant success. Analysis of the data show that 40% of the dogs enrolled in the study had a reduction in severity and frequency of seizures. The paper is published in Frontiers of Veterinary Medicine (https://www.frontiersin.org/articles/10.3389/fvets.2022.939966/full)
While CBD has been widely believed to have potential as an option for seizures in dogs, there have been few studies on the topic prior to this study showing efficacy in dogs.
The research team, led by Dr. Gabriel Garcia of the University of Florida Veterinary School, conducted a 2 yearlong study examining a 3 month-long treatment in a placebo blinded controlled clinical trial where dogs were either given a placebo or ElleVet Sciences CBD+CBDA oil. When compared to the placebo group, the frequency and severity of seizures dropped significantly for 40% of dogs on the ElleVet oil. All dogs enrolled were on concurrent seizure products with no adverse events occurring.
Chief Medical Officer of ElleVet Sciences, Dr. Joe Wakshlag says, “This can be a regimen that is safe and effective and is a worthwhile addition to the current regimen for refractory seizures when commonly used products are not working as well as intended. This study has similar success to what is observed in people, and I am extremely pleased to be able to share the results with the veterinary community.”
According to ElleVet Sciences Co-Founder Amanda Howland, “It is not surprising to us that there were positive results as CBD has been used in the human realm for some time. What was surprising was the low dose that is needed of our full spectrum product compared to CBD isolate used in human studies.”
Pet parents and veterinarians interested in trying ElleVet Sciences for dogs needing neurological support can find ElleVet Products either online at www.ellevetsciences.com or through their veterinarian.
ElleVet Sciences is a leading science-focused pet CBD+CBDA company based in Portland, Maine, and the first and only company to conduct clinical trials with proven results using their cannabinoid and terpene oil blend. ElleVet Sciences was founded by Christian Kjaer and Amanda Howland in 2017, and the entire ElleVet team combines science, veterinary backgrounds with a dedication to animals through research and innovation. For more information, please visit https://www.ellevetsciences.com or on social media at @Ellevetsciences on Facebook and Instagram.
- Minnesota’s Black cannabis users far more likely to face arrest than white onesBlack Minnesotans are nearly five times as likely to be arrested on marijuana charges as white ones, according to the latest data from the Bureau of Criminal Apprehension. It’s a disparity that has persisted for years, despite data showing that Black and white residents use cannabis at similar rates.
- Lawmakers ask MO governor to add cannabis legalization in special sessionA bipartisan group of lawmakers and activists are calling for Missouri Gov. Mike Parson to include marijuana legalization on the agenda of the legislature’s upcoming special session.
- In Brief: Pa. Governor Accepting Cannabis Pardon Requests in Sept.Pennsylvania Gov. Tom Wolf and Lt. Gov. John Fetterman announce the PA Marijuana Pardon Program, offering expedited pardon reviews to people convicted of only minor cannabis possession for personal use.
- Michigan State Police stops cannabis testing after false positivesMichigan State Police have acknowledged that its blood tests for marijuana are producing false positives for THC, and it will immediately halt testing.
- Missouri Dems expect boost from cannabis, but split on specificsSupport for legalization and heartburn about the amendment’s details have led to soul-searching among Democratic Party officials across the state. The consternation is particularly acute among Black Democratic leaders.
- Signatures on Nebraska medical cannabis petitions to get another lookThe Nebraska Secretary of State’s Office has agreed to take another look at signatures submitted by a group seeking legalization of medical marijuana to determine if they should have been counted.
- Nebraska senator pledges to seek special session to legalize medical cannabisAdvocates for legalization of medical marijuana were pursuing a trio of options Tuesday after their attempt at qualifying the issue for the November ballot fell short.
- Adult-use cannabis unlikely to be on Oklahoma ballot in NovemberThe Yes on 820 campaign faces several obstacles in the last part of its journey to the ballot as another challenge period will last at least 10 business days and the state Election Board needs time to print ballots for overseas voters.
- Lawsuit asks to block cannabis legalization from Missouri ballotAn anti-drug legalization activist has filed a lawsuit arguing a recreational marijuana initiative petition was improperly certified by Missouri Secretary of State Jay Ashcroft and should not appear on the November ballot.
- Cannabis legalization advocates turn THC customers into political alliesNow that Minnesota has legalized hemp-derived THC products as of July 1, proponents of full legalization are activating a new resource in the political battle over the green plant’s future: customers.